ITOS (iTeos Therapeutics Inc) Net Profit
iTeos Therapeutics (ITOS) is a promising immuno-oncology brand with high therapy efficacy that minimizes geopolitical risks due to the humanitarian status of its developments. The company's net income reflects its financial performance, where -0.21 indicates the level of this metric. Success is driven by outstanding scientists in Belgium and the US, who are implementing bold cancer treatment ideas on an innovative platform.
Analytical breakdowns and data insights for company iTeos Therapeutics, Inc. (ITOS)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio iTeos Therapeutics|ITOS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio iTeos Therapeutics Inc|ITOS - Company Total Debt|Debts to Book Capitalization iTeos Pharma|ITOS - Company Long-Term Debt|Company Short-Term Indebtedness iTeos Therapeutics|Immediate Liquidity iteostherapeutics.com
- net income and valuation multiples indicators:
Summary company analysis:iTeos Therapeutics
iTeos Therapeutics' profit reflects the difference between total revenues and all operating expenses, allowing for an assessment of cost management efficiency and dividend payout potential. For iTeos Therapeutics, which invests in R&D and retains scientists through stock options, the company's net performance on the chart serves as an indicator of the balance between costs for onco-immunology development and the market value of the antibodies being created.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Net Financial Result Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net Income|UPB: Profit After Payment of Taxes|ZBIO (Zenas Biopharma) - Net Profit|Company Net Income Immunome Inc IMNM|Company Net Income Gossamer Corp (GOSS)|KALV - Company Net Income|Company Net Income Septerna Inc SEPN|Net Financial Result pieris.com (PVLA)|SVRA: Net Income|Final Profit RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Net Income|ATXS: Profit After Payment of Taxes|ENGN (enGene Holdings Inc.) - Net Profit|RAPT: Final Profit|Net Profit JBIO|ACRS - Company Net Income|Company Net Income Kyverna KYTX|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|VTYX - Net Profit|Theratechnologies (THTX) - Company Net Income|Profit After Tax AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Net Profit|Company Net Income Agenus, Inc AGEN|Net Income CLYM (Climb Bio Inc)|Net Profit zurabio.com (ZURA)|aTyr Pharma - Net Income|Profit After Payment of Taxes ADAG (Adagene Inc)|Ikena Oncology, Inc. - Net Profit|Net Financial Result Shattuck Labs, Inc. STTK|EQ: Net Profit|Net Income Connect Biopharma Holdings Limited|Company Net Income Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Net Financial Result|Net Profit IFRX|Net Financial Result X4 Pharmaceuticals, Inc|Adicet Bio, Inc. - Net Income|Profit After Payment of Taxes CELU (Celularity Inc)|INMB - Company Net Income|Company Net Income Barinthus Biotherapeutics PLC|Kezar Life Sciences, Inc (KZR) - Company Net Income|SABS - Net Financial Result|Company Net Income Akari Therapeutics|Enlivex Therapeutics, Ltd. - Profit After Tax|Net Profit QTTB|GOVX (GeoVax Labs) - Final Profit|Net Profit EDSA (Edesa)|Net Profit iBio Corporation IBIO|CARM - Company Net Income|Final Profit XTLB (xtlbio.com)|boltbio.com (BOLT) - Company Net Income|Net Income HCW Biologics|APVO (Aptevo Therapeutics, Inc.) - Net Profit|Net Profit aimimmuno.com|Net Income ADTX (Aditxt)|GRI (gribio.com) - Final Profit|Net Profit XRTX (XORTX Therapeutics)|Net Financial Result Vyome Holdings Inc. (HIND)|REVB - Company Net Income|Indaptus Corp (INDP) - Net Income|Scinai Immunotherapeutics (SCNI) - Company Net Income|Net Income CalciMedica|Net Income AFMD|Net Profit Allakos Therapeutics|Company Net Income HOOKIPA Pharma Inc. (HOOK)|igmbio.com - Company Profit|Net Profit OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Company Net Income|Third Harmonic Bio, Inc. - Net Profit